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Background: We investigated the applicability and feasibility of perceptive computing assisted gait analysis in
multiple sclerosis (MS) patients using Microsoft Kinect™. To detect the maximum walking speed and the degree of
spatial sway, we established a computerized and observer-independent measure, which we named Short Maximum
Speed Walk (SMSW), and compared it to established clinical measures of gait disability in MS, namely the Expanded
Disability Status Scale (EDSS) and the Timed 25-Foot Walk (T25FW).
Methods: Cross-sectional study of 22 MS patients (age mean ± SD 43 ± 9 years, 13 female) and 22 age and gender
matched healthy control subjects (HC) (age 37 ± 11 years, 13 female). The disability level of each MS patient was
graded using the EDSS (median 3.0, range 0.0-6.0). All subjects then performed the SMSW and the Timed 25-Foot
Walk (T25FW). The SMSW comprised five gait parameters, which together assessed average walking speed and gait
stability in different dimensions (left/right, up/down and 3D deviation).
Results: SMSW average walking speed was slower in MS patients (1.6 ± 0.3 m/sec) than in HC (1.8 ± 0.4 m/sec)
(p = 0.005) and correlated well with EDSS (Spearman’s Rho 0.676, p < 0.001). Furthermore, SMSW revealed higher
left/right deviation in MS patients compared to HC. SMSW showed high recognition quality and retest-reliability
(covariance 0.13 m/sec, ICC 0.965, p < 0.001). There was a significant correlation between SMSW average walking
speed and T25FW (Pearson’s R = -0.447, p = 0.042).
Conclusion: Our data suggest that ambulation tests using Microsoft Kinect™ are feasible, well tolerated and can
detect clinical gait disturbances in patients with MS. The retest-reliability was on par with the T25FW.
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Multiple sclerosis (MS) is a common chronic inflamma-
tory and neurodegenerative disease that normally begins
in young adulthood, typically affecting patient quality of
life and leading to high rates of early retirement [1-4].
Impairment of gait and balance are major factors that
restrict daily activity [5] and may occur as early as after
a first clinical episode [6-8].
In current clinical practice, balance and gait impairment
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unless otherwise stated.and patients’ reported maximum walking distance: The
Kurtzke‘s Functional Systems and Expanded Disability
Status Scale (EDSS) [9] are widely used both in clinical
practice and for clinical trials. The EDSS provides a
good overview of current neurologic status, gait impair-
ment and mobility dysfunction, but it has limitations. It
is a relatively subjective measure with high intra- and
inter-rater variability and quantifying mild symptoms
and symptom progression is challenging [10,11]. The
Timed 25-Foot Walk (T25FW) measures the time a
patient takes to walk 25 feet at maximum speed. As part
of the Multiple Sclerosis Functional Composite (MSFC),
the T25FW is currently the most widely implemented
method to objectively quantify gait disability in clinical
MS trials and, to a lesser extent, clinical practice [12,13].
Although an excellent method of quantifying overall gaitl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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walk a set distance [14]. As alternatives to the T25FW,
timed walking tests might improve reliability. In particular,
the 2-minute walk test is proposed as an additional out-
come parameter in clinical trials [15].
Recently, more objective motion capture systems (for
an overview see [16]) have been proposed as tools for
detecting the pattern of gait impairment more precisely
than clinical examination using conventional tools (i.e.
EDSS) [17,18]. However, none of these systems has found
its way into clinical routine yet, and are therefore rarely
available in outpatient clinics and neurologic practices.
With an infrared light camera system, the Microsoft
Kinect™, which was originally developed for video gaming,
detects anatomical landmark positions in three dimen-
sions (3D) [19]. This function is based on a decision forest
method that harnesses mass data of sensor-recorded skel-
etal joint movements [20]. Using the programming inter-
face made available via the Kinect software development
kit (SDK) [21], it has in the past been employed to detect
balance and motion of healthy subjects [22,23] and stroke
patients [24,25]. Furthermore, some few studies have re-
ported methods for gait parameter approximation using
Kinect [26-28], however, none of these has been applied to
patients with MS.
The objective of this study was to evaluate the feasibil-
ity of computerized versions of walking tests using
Microsoft Kinect and to compare the resulting findings
for MS patients with low to moderate neurological impair-
ment to those for healthy controls. We established the
Short Maximum Speed Walk test (SMSW) as a measure
to analyse patients’ gait speed and degree of sway. We re-
port feasibility, reliability and correlation of results with
those of EDSS and the T25FW.
Methods
Ethics
The local ethics committee of the Charité – Universitäts-
medizin Berlin approved the study (EA1/225/12). It was
conducted in accordance to the Declaration of Helsinki in
its currently applicable version. All patients and healthy
subjects gave written informed consent.
Patients
Twenty-two patients with diagnosed MS according to
the current panel criteria [29] (age mean ± SD 43 ± 9
years, 13 female) and 22 age and sex matched healthy
controls (HC) (age 37 ± 11 years, 13 female) were enrolled
in the study. MS patients were recruited from on-going
clinical trials at Charité’s neuroimmunology outpatient
clinic. HC were recruited from volunteers. Blinding was
not attempted, since the operators knew many subjects
and visual contact was mandatory. MS patients were first
clinically graded using EDSS (median 3.0, range 0.0 – 6.0)under supervision of a neurologist. The EDSS is calculated
from a detailed neurological examination using functional
system scores that assess the visual system function,
brainstem function, pyramidal tract function, cerebellar
function, sensory system function, bowel and bladder
function, cerebral function and patient ambulation [9].
Subjects additionally performed the T25FW component
of the Multiple Sclerosis Functional Composite (MSFC)
[30]. T25FW results were not available from eight of the
22 HC, and one of the 22 MS patients. The first 8 HC
had been tested before the T25FW was added to the
study protocol and the MS patient could not complete
the study in full due to time constraints.
Perceptive computing assisted motor assessment
We used custom-built software running on a Windows
8 (Microsoft Corp., Redmond, WA, USA) computer with
Kinect Software Development Kit (SDK) version 1.7. A
Microsoft Kinect sensor was attached to a fixed pole,
thereby covering a triangular area of roughly 2.5×2.5 m.
The Kinect system records live videos with a conventional
camera and combines these with depth information com-
prising a combined feed from an infrared projector and an
infrared camera. The Kinect Software Development Kit
(SDK) then detects the human subject in the 3D video in
real-time and models an artificial skeleton with 20 joints
of an individual subject and their movement over time
[19,21]. A sample of the process is shown in Figure 1 and
Supplementary Video 1. Each subject was tested in an
evenly lit room in a single session of sequential tests. All
subjects were given the same instruction as specified in a
standardized test procedure: “Walk as fast as you can to-
wards the sensor”. The starting point for walking was ap-
proximately two metres outside the detection range of the
sensor. We postulated that this would allow the subject to
reach maximum walking speed before reaching the meas-
urement zone. The start was given as a voice command.
An automatic computer-generated sound signalled the
subject to end the experiment after leaving the opposite
edge of the sensor measurement zone.
Short Maximum Speed Walk test analysis
The SDK’s recorded skeletal information was post-
processed at a frame-rate of 30/s. To assess walking speed
and related parameters we extracted the hip-centre joint
coordinates over time. An overview of all parameters is
given in Table 1. In detail, the data post-processing and
analysis comprised the following steps:
First, joint coordinates were normalized, correcting for
sensor tilt and walking direction of the subject by com-
puting a linear approximation of the hip-centre move-
ment, translating the start of the movement to the point
of origin and rotating the direction of movement onto
the positive Z-axis.
230 cm
120 cm
K
S
280 cm
200 cm
A B
0 5 10 15 20 25 30
−0.5
0
0.5
1
1.5
2
2.5
Position(Frames)
Co
or
di
na
te
 v
al
ue
 (m
)
]
Normalised Hip-Center Movement
 
 
x
y
z
C
Figure 1 System setup. A) Schematic system setup (view from above): The Kinect sensor (K) was positioned 140 cm above ground, angled -9°
towards the floor. Starting (S) about 2 metres in front of the beam path (light blue area), subjects walked with maximum speed towards the
Kinect camera (red arrow). Recording started and stopped automatically as sensors detected the subjects entering and leaving the detection zone
(dark blue area). B) Sample screenshot of a healthy subject during the test with skeleton projection (green lines). The hip-centre joint (marked as
red dot) was used as the data source for analysis. C) Sample data from single healthy subject after normalization. At the position of the red arrow
a measurement frame was removed due to a detected calibration jump.
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Table 1 Overview of SMSW parameters
Parameter Unit Description Interpretation
Average walking
speed
m/s Average speed during the measurement calculated
as observed distance divided by observed time
Main outcome parameter; measures a subject’s
average walking speed during the test
Speed deviation m/frame Standard deviation of speed between sequent frames Measure of directional speed homogeneity
3D direction
deviation
m2 Mean square error from the Euclidean distance between
the actual position and the position from a linear model
approximation over the main z-vector
Combined expression of how much directional,
up/down and left/right variability a subject’s gait
shows
Left/right deviation cm Left/right deviation between the actual position and the
position as determined by a linear model approximation
over the main z-vector
Parameter describes a subject’s left/right
movement during the walking test.
Up/down deviation cm Up/down deviation between the actual hip center position
and the position from a linear model over the main z-vector.
Parameter describes a subject’s up/down
movement during the walking test.
Observed time s Total time the subject was tracked Quality parameter
Observed distance m Total distance the subject was tracked Quality parameter
Jump count Number of detected calibration jumps during the measurement Quality parameter
Jump distance m Mean distance of all calibration jumps detected during the
measurement
Quality parameter
Measurement length frames Total number of frames collected Quality parameter
Readout parameters are given in bold; quality parameters are shown in regular font.
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form of tracking errors, or calibration jumps) were inev-
itable. Specifically, detection of the spatial location of
the crucial hip-centre joint by the SDK system was
clearly sometimes erroneous as determined by visual
inspection. Furthermore, the SDK’s in-built error detec-
tion system (SDK Recognition Quality) was unable to
identify these artefacts with sufficient accuracy, and in-
stead falsely reported all joint detections as successful.
To address this problem, we developed an alternative
error correction technique. Here, we mathematically ex-
tracted the acceleration of the joint movement between
two frames as recorded by the SDK system. We ana-
lysed the transition between the points in terms of a
subject’s overall acceleration and averaged these values
across the study cohort. We found that if aggregated ac-
celeration over all coordinate axes exceeded a threshold
of 0.6 m/frames2, the frames were likely to be an arte-
fact. As such they were flagged as suspected tracking
errors (“calibration jump”) and excluded from further
analysis.Table 2 Quality parameters
HC
Description Mean SD Min Max
Observed time (sec) 1.232 0.399 0.780 2.636
Observed distance (m) 2.150 0.087 1.993 2.423
Number of calibration jumps 0.9 1.0 0.0 3.3
Average calibration jump distance (m) 0.091 0.033 0.044 0.168
Measurement length (frames) 37.3 12.2 24.3 79.7
A detailed description of investigated parameters is given in Table 1.
Abbreviations: HC healthy controls, MS multiple sclerosis patients, SD standard deviaUsing the calibration jump-corrected data, we computed
the SMSW test parameters given in Table 1, which were
then used for statistical analysis.
All data post-processing and analysis was performed
using Matlab 2012A (Mathworks, Ismaning, Germany).
Analysis of measurement quality
We derived several quality parameters and investigated
the recognition quality of the central joint hip-centre
(Table 2). The frequency of calibration jumps was compar-
able between HC and MS patients. However, the average
jump size was significantly higher in HC than MS patients.
There was a strong correlation between walking speed
and average jump distance (Pearson’s R = 0.778, p < 0.001),
suggesting that the reason for this difference was the
higher speed of HC ambulation. Furthermore, the faster
people were walking, the shorter were both the observed
time (Pearson’s R = -0.967, p < 0.001) and the observed
distance (Spearman’s Rho = -0.686, p < 0.001). This was
probably caused by the short initialisation period the sys-
tem needed when a subject walked into the detectionMS t test
Mean SD Min Max Mean Δ SD Δ P
1.535 0.363 0.998 2.376 0.303 0.115 0.012
2.283 0.089 2.098 2.443 0.134 0.027 <0.001
0.9 1.3 0.0 5.3 −0.05 0.35 0.897
0.058 0.013 0.029 0.074 −0.033 0.009 0.002
46.8 10.9 30.7 72.0 9.5 3.5 0.009
tion.
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imally longer time period and distance than HC, although
the predefined test criteria were identical (Table 2).
Analysis of immediate retest reliability
T25FW tests were performed twice and the SMSW three
times in a row to assess the retest reliability. T25FW, aver-
age speed and SMSW showed excellent retest reliability
with ICC > 0.9 in HC and MS. Speed deviation and up/
down deviation showed good reliability, whereas reliability
for 3D direction deviation and left/right deviation was
only moderate (for details, see Table 3). When data was
not corrected for calibration jumps, ICC was considerably
lower (not shown).
Statistical analysis
Immediate retest reliability was analysed using intra-class
correlation coefficients (ICC) with a one-sided, random
model. Test results between MS patients and HC were
compared using t-tests. When equal variances could be as-
sumed (Levene’s test p > 0.05), p-values from independent
sample Student’s t-tests are given. When equal variances
could not be assumed (Levene’s test p < 0.05), results
from the Welch’s t-test are given. The association be-
tween T25FW and SMSW measures was investigated
using Pearson’s correlation analysis and a Bland-Altman
analysis. Correlation with EDSS and functional system
scores was investigated with Spearman’s Rho analysis
due to the ordinal nature of EDSS data.
Statistical analysis was performed using SPSS version
21 (IBM, Armonk, NY, USA). A p < 0.05 was deemed
significant. All tests should be understood as exploratory
data analysis as no prior power calculation and subse-
quent corrections for multiple testing were applied.
Results
Five gait parameters were derived from the hip-centre
joint movement during the walk test and compared be-
tween HC and MS patients. Average walking speed was
the main test parameter, while the four other parametersTable 3 Immediate retest reliability
HC
Description ICC CI LOW
T25FW* 0.905 0.714
SMSW Average speed 0.989 0.979
SMSW Speed deviation 0.742 0.480
SMSW 3D direction deviation 0.429 −0.152
SMSW Left/right deviation 0.533 0.058
SMSW Up/down deviation 0.958 0.916
*) The T25FW analysis is based on data from 21 MS patients and 14 HC.
Abbreviations: HC, healthy controls; MS, multiple sclerosis patients; SD, standard dev
CI, confidence interval; LOW, lower bound; UP, upper bound.described gait stability in different dimensions (Table 1).
MS patients were significantly slower than HC in aver-
age walking speed. In MS patients, 3D direction devi-
ation and left/right deviation were significantly higher
than in HC, whereas there was no significant difference
between speed deviation and up/down deviation (Table 4
and Figure 2).
Comparison between SMSW and T25FW
There was a significant but only moderate correlation
between T25FW and SMSW average walking speed
(Pearson’s R = -0.447, p = 0.042) in MS patients (Figure 3).
In a Bland-Altman analysis comparing T25FW with
SMSW and including HC and MS patients, the differ-
ence between the measures was 0.4 ± 1.3 sec (mean ±
SD) (Figure 3). There was no correlation between the
test difference and observed time, meaning that these
differences could not be explained by a higher estima-
tion error in tests with shorter measurement times.
Association with EDSS and functional system scores
Both T25FW and SMSW correlated equally well with
EDSS total score (Table 5A) and EDSS ambulation score
(Table 5C). In the EDSS functional system scores
(Table 5B), T25FW correlated mainly with visual func-
tion, cerebral function but not with pyramidal function.
In contrast, SMSW did not correlate with visual func-
tion but with brainstem function, pyramidal and cere-
bral function (Table 5). Gait stability as expressed by the
four deviation parameters correlated to a lesser extent
with EDSS (Table 5).
Discussion
In this cross-sectional study we investigated the applic-
ability and feasibility of perceptive computing assisted
motion analysis in MS patients using the Microsoft
Kinect system. Our primary question was whether skel-
etal tracking data recorded by the device’s SDK program
would yield reliable information for gait analysis. Using
only the hip-centre joint, we established the test SMSWMS
CI UP ICC CI LOW CI UP
0.969 0.990 0.976 0.996
0.995 0.980 0.960 0.991
0.884 0.901 0.800 0.955
0.744 0.540 0.072 0.794
0.790 0.596 0.186 0.819
0.981 0.936 0.871 0.971
iation; T25FW, Timed 25-Foot Walk; ICC, 1-way Intra-class correlation coefficient;
Table 4 Comparison between healthy controls and multiple sclerosis patients
Parameter HC MS t test
Mean SD Min Max Mean SD Min Max Mean Δ SD Δ P
Average speed (m/s) 1.852 0.366 0.919 2.557 1.555 0.294 1.029 2.131 −0.297 0.100 0.005
Speed deviation (m/frame2) 0.0070 0.0010 0.0056 0.0099 0.0068 0.0011 0.0053 0.0092 0.000 0.000 0.437
3D direction deviation (m2) 0.00040 0.00015 0.00012 0.00064 0.00072 0.00026 0.00016 0.00125 0.00032 0.00007 <0.001
Left/right deviation (cm) 1.122 0.243 0.638 1.477 1.537 0.301 0.693 2.069 0.415 0.082 <0.001
Up/down deviation (cm) 1.818 0.596 0.997 2.902 1.777 0.579 0.617 2.924 −0.041 0.177 0.817
See Table 1 for a detailed description of the parameters assessed.
Abbreviations: HC healthy controls, MS multiple sclerosis patients, SD standard deviation.
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Additionally, we analysed the SMSW left/right and
up/down deviation of MS patients gait in comparison
to HC.
Using the SMSW, we were able to detect differences
in average walking speed between MS patients and HC.
Several gait stability parameters also showed promising
results: Especially 3D direction deviation and left/right
deviation showed prominent differences between HC and
MS patients. The lateral sway of MS patients (described
by the parameter left/right deviation) detected by our test
suggests that stability impairments are indeed detectable
by perceptive computing systems, even over limited
observation time and distance (although some types of
gait variability may only become evident over longer
distances) [31].
The linear distance covered by the recognition area
was only 2.2 metres (see Figure 1 and Table 2), and con-
sequently only a few steps of each subject were analysed.
Despite this short walking and recording time, the over-
all detection quality of the target hip-centre joint of the
SMSW over time was excellent. Calibration jumps (i.e.
tracking errors by the SDK system) presented regularly
(see Table 2), however, these could be filtered out by ap-
plying a custom-built filter developed during the analysis
of this experiment. After filtering out the calibration
jumps, the retest reliability of the SMSW average walking
speed parameter was excellent and on par with T25FW.
The gait stability parameters showed less retest reliability.
This was likely due to the fact that most differences be-
tween MS patients and HC were only marginally signifi-
cant. The reliability of the gait stability measurements was
superior in MS patients, where a higher signal-to-noise ra-
tio was expected due to weaker gait stability. Additionally,
the detection limit was heavily influenced by the joint rec-
ognition quality of the sensor. In fact, one measure (3D
direction deviation), originally designed to detect changes
in walking stability, proved to be very sensitive to calibra-
tion jumps in walking direction, which primarily occurred
at faster walking speed.
In combination, these data suggest that an assessment
employing gait analysis at lower walking speed mightimprove detection of gait variability and stability in mobil-
ity impaired patients. This would not only lower detection
errors in the form of calibration jumps but would also
allow the system to record several step cycles for a more
robust analysis. This is supported by a previous study in-
vestigating a Kinect-based system for gait measurements
using 3D point cloud information instead of skeletal track-
ing data, which reported accurate estimation of gait pa-
rameters compared to a Vicon motion analysis system in
healthy volunteers [32]. A second study used skeletal data
from all reported joints to analyse a postural control as-
sessment battery in healthy subjects [23]. Our study adds
to these findings and shows that Kinect-based motion ana-
lysis is also feasible in MS patients and is able to reliably
detect gait differences in comparison to healthy controls.
Although the experimental setups and analysis approaches
differ, all three studies show that inexpensive 3D percep-
tual computing can be reliably used to quantify motion
impairment. Furthermore, a recent work of Stone and
Skubic showed, Kinect can also be installed in the patient’s
home as a means of frequently and conveniently assessing
gait [28].
We expected that SMSW average speed and the
T25FW would yield similar results. However, MS pa-
tients’ results sometimes differed strongly in the two
tests. Although typical MS symptoms like reduced mus-
cular strength, spasticity or balance deficiency are
widely known to fluctuate [33], it is unlikely that ran-
dom irregularities or gait variability are the key factors
in this discrepancy, because retest reliability was high in
both tests.
Instead, a different influence of functional impairments
on both tests seems possible. SMSW and T25FW corre-
lated well with overall EDSS degree of neurological disabil-
ity. However, when drilling-down by comparing individual
parameter results to the corresponding EDSS functional
system scores (FS), we were surprised to find a difference
between the SMSW and the T25FW: Whereas SMSW
average walking speed showed a moderate correlation to
cerebral function, T25FW results correlated with visual
function, and SMSW walking speed showed correlation
with the pyramidal scores of the EDSS.
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Figure 2 Test outcome differences. Box plots of test outcome
measurements (red =MS patients, grey = healthy subjects). Significance
levels from t-tests: *** = p < 0.001; ** = p < 0.01; * = p < 0.05.
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spasticity clearly restricts the gait of many MS patients
[34,35]. However, as stated above, we found no correl-
ation between the T25FW and the pyramidal function
score of the EDSS. This is in discrepancy with previous
findings, such as those of Phan-Ba et al. [36], and likely
explained by the only mild pyramidal impairment of
many patients in our study (41% patients with FS ≤ 2 ).
In contrast to T25FW, SMSW correlated with pyramidal
functional system scores. This might be explained by
findings from previous studies where MS patients, per-
forming the T25FW, accelerated walking speed after a
relatively slow start [36,37]. Because muscular rigidity is
triggered by postural changes [38], such as starting from
a static position to walk, we may have detected a starting
weakness of spastic patients. Thus, a patient, who begins
moving more slowly, might show a slower walking time
at SMSW average walking speed compared to T25FW.
In the T25FW a slower speed at start might level over
the longer distance. In this regard SMSW average walk-
ing speed may be more sensitive to impaired initiation
of movement in MS patients than the T25FW. We did
not evaluate spasticity with a validated assessment, so
we were not able to further pursue the question of
whether the SMSW could be a marker for minor pyram-
idal weakness.
An exploratory pilot study of this type has some limita-
tions. Only Kinect-derived skeletal tracking information
generated by the SDK was used [19]. Although not within
the scope of the present study, it is conceivable that exclu-
sive or hybrid inclusion of raw sensor data might yield
additional or better results. Furthermore, we neither se-
lected MS patients with specific and well-established
motor symptoms or gait disability, nor did we compare
SMSW test results to objective gait measures other than
T25FW. The analysis between SMSW, T25FW and EDSS
functional system scores should be treated as preliminary
and the results should be interpreted with care. However,
the demonstrated correlations fit well within the expected
clinical framework and the results of previous studies. As
such, our results can be expected to serve as a basis for
confirmatory studies. Most importantly, the ability of
SMSW measurements to detect changes longitudinally
and the retest reliability of the test needs to be validated in
a follow-up study.
Conclusion
Perceptive computing-based detection of ambulation
speed via the joint hip-centre was feasible and reliable.
SMSW average walking speed was a valid parameter as
demonstrated by retest reliability results and the strong
correlation with established clinical scores, such as the
T25FW and EDSS. A notable difference was the slower
walking speed of MS patients measured using SMSW
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Figure 3 SMSW in comparison with the T25FW. Measuring agreement of gait speed detection of MS patients (red dots) and healthy subjects
(grey triangles) with standard T25FW and SMSW. To be able to directly compare SMSW and T25FW in a Bland-Altman analysis, the SMSW time
equivalent of walking 25-feet at the detected average speed was calculated. A) Results are plotted against each other. The solid line represents
an R2 of 0.392 from a linear regression analysis; the long dashed lines are 95% confidence intervals to the mean. The short-dashed line represents
the theoretical test equality (T25FW = SMSW). B) Bland-Altman plot comparison between T25FW and SMSW average speed. B) The difference of
the mean is -0.4 sec (solid line). Long dashed lines are 2x standard deviation.
Behrens et al. Journal of NeuroEngineering and Rehabilitation 2014, 11:89 Page 8 of 10
http://www.jneuroengrehab.com/content/11/1/89(mean distance: 2.2 metres) compared to T25FW (mean
distance: 7.6 metres). The gait stability parameters
showed greater left/right deviation in MS patients com-
pared to HC. The analysis approach presented here
shows promise as an objective technique for detectingTable 5 Correlation between test outcomes and EDSS
A B
Parameter Total score FS VIS
Median 3.0 0 12
Min 0.0 1 9
Max 6.0 2 1
3+
T25FW* Rho 0.694 Rho 0.492
P <0.001 P 0.023
SMSW Average speed Rho −0.701 Rho 0.060
P <0.001 P 0.789
SMSW Speed deviation Rho 0.276 Rho 0.286
P 0.213 P 0.198
SMSW Derived T25FW Rho 0.676 Rho −0.060
P 0.001 P 0.789
SMSW 3D direction deviation Rho 0.439 Rho 0.086
P 0.041 P 0.705
SMSW Left/right deviation Rho 0.429 Rho 0.072
P 0.046 P 0.750
SMSW Up/down deviation Rho −0.134 Rho −0.122
P 0.551 P 0.590
P values are given in italic; correlation coefficients from tests with significant results
Spearman’s Rho analysis compared to the results of investigated measures and stan
Rho analysis results. *) The T25FW analysis is based on data from 21 MS patients an
Abbreviations: T25FW Timed 25-Foot Walk, EDSS Expanded Disability Status Scale, FS
PYR pyramidal tract score, cer cerebellar score, SENS sensory system score, B&B bowand assessing of gait pattern and as a simple and afford-
able tool in the clinician’s toolbox. Finally, this study
provides evidence that further investigation of gait with
periodic Kinect-measurements may give new insight into
the disease progression of MS.BS PYR cer SENS B&B CER
7 3 4 2 9 5
10 6 8 8 7 9
5 8 6 10 5 8
5 4 2 1
0.304 0.161 0.394 −0.081 0.397 0.539
0.180 0.485 0.077 0.727 0.075 0.012
−0.516 −0.634 −0.355 −0.126 −0.204 −0.430
0.014 0.002 0.105 0.578 0.362 0.046
0.369 0.024 0.122 −0.453 0.155 0.291
0.091 0.917 0.588 0.034 0.491 0.189
0.516 0.639 0.327 0.090 0.204 0.428
0.014 0.001 0.137 0.690 0.362 0.047
0.411 0.196 0.074 0.048 −0.099 0.317
0.057 0.382 0.743 0.834 0.662 0.151
0.392 0.191 0.033 0.007 −0.125 0.317
0.071 0.395 0.884 0.974 0.579 0.151
−0.301 −0.181 −0.264 −0.246 0.056 −0.397
0.173 0.421 0.236 0.269 0.806 0.067
are given in bold. A) Overview of EDSS distribution and results from a
dard T25FW results. B) Detailed overview of FS distribution and Spearman’s
d 14 HC.
EDSS functional system score, VIS visual system score, BS brainstem score,
el and bladder score, CER cerebral score.
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